Increasing enrollment in health insurance is one of the primary goals of the health reform law. The CMS took a major step to achieve that this week by signing agreements with five Web-based insurance broker firms to help enroll Americans in the insurance exchanges in the 35 states where the federal government will run them.
Increasing enrollment in health insurance is one of the primary goals of the health reform law. The CMS took a major step to achieve that this week by signing agreements with five Web-based insurance broker firms to help enroll Americans in the insurance exchanges in the 35 states where the federal government will run them.
The participating Web-based brokers each will set up a website that is linked to the state insurance exchange websites. Individuals will be able to enter information on where they live, age and income to determine plan rates and whether the individual is eligible for subsidies. It will be possible for the Web-based brokers to determine eligibility because their sites will communicate with the federal data hub. If necessary, customers will be able to contact a broker, either online or over the phone, for support.
Read the full story: http://bit.ly/13Hckna
Source: Modern Healthcare
Earlier this summer, the CMS released draft agreements for Web-based brokers looking to enroll people in the federally run exchanges. It will make available an application programming interface that would let them integrate their websites with the exchange offerings.
Emily Goldberg Shares Insights as a Genetic Counselor for Breast Cancer Risk Screening
October 30th 2023On this episode of Managed Care Cast, Emily Goldberg, MS, CGC, a genetic counselor at JScreen, breaks down how genetic screening for breast cancer works and why it is so important to increase awareness and education around these screening tools available to patients who may be at risk for cancer.
Listen
POSITIVE Trial Update on Patients With Breast Cancer Attempting Pregnancy
December 8th 2023At last year’s San Antonio Breast Cancer Symposium, POSITIVE trial primary outcome data were presented on breast cancer–free interval, with women who paused endocrine therapy to attempt pregnancy having a similarly small rate of recurrence vs external controls from the SOFT and TEXT trials: 8.9% vs 9.2%.
Read More
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
Patients With RA in Remission Withdrawing From TNF Inhibition Show Flare Increases
December 8th 2023New data presented at ACR 2023 highlighted the differences in rates of flares and Boolean 2.0 remission rates compared to patients with rheumatoid arthritis who continued a tumor necrosis factor inhibitor (TNFi).
Read More